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Abstract 8 
Exocrine Pancreatic Insufficiency (EPI) implies maldigestion, being pancreatic enzyme replacement 9 
therapy the treatment to enhance digestibility. This study aims at analysing the influence of cheese-related 10 
factors and intestinal conditions on macronutrients digestibility.  Fresh-cow, fresh-goat, mild and aged 11 
cheeses were in vitro digested under different intestinal conditions of pH (6 or 7), bile concentration (1 or 12 
10mmol/L) and pancreatic enzymes (0-4000 LU/g fat) in order to in vitro mimic the intestinal conditions 13 
of a healthy adult and of an individual suffering of EPI. Under intestinal conditions of EPI (pH 6, bile 14 
1mmol/L), lipids of fresh-goat and aged cheeses were more easily digested than those of fresh-cow and 15 
mild cheeses. In fact, 2000 LU/g fat of enzymatic dosage was enough to achieve a lipolysis extent of 80 16 
and 100% 100 % in aged and fresh-goat cheeses, respectively. In contrast, proteolysis was higher in fresh-17 
cow cheese and ripened (mild or aged) than in fresh-goat one regardless the intestinal conditions. Only in 18 
ripened-cheeses, proteolysis significantly increased at dose of enzymes does. 19 
 20 
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1. Introduction 22 
Food lipids are important in diets of infants and children, especially when digestive disorders 23 
occur such as exocrine pancreatic insufficiency (EPI), as they supply metabolic energy and phospholipids, 24 
the main constituents of biological membranes (Briefel, Reidy, Karwe, & Devaney, 2004). Among lipid-25 
containing foods, dairy products are highly consumed by childhood population (Calvo-Lerma et al., 26 
2019). Cheese is particularly rich in lipid and a good source of essential nutrients such as protein, 27 
bioactive peptides, vitamins and minerals (Walther, Schmid, Sieber, & Wehrmüller, 2008). The three 28 
major constituents of cheese are protein, fat and water, and all them conform their matrix structure. 29 
Protein matrix consists of casein particles that are bonded with calcium ions through electrostatic forces 30 
or hydrophobic aggregations, which entrap fat globules. Water content depends on the manufacturing 31 
process that directly influences lipid and protein content. Cheese can be consumed directly after its 32 
elaboration (fresh cheese), or after a ripening stage (ripened cheese). During ripening, proteolysis 33 
disaggregates the casein network that conforms the cheese matrix, while lipolysis is the main process 34 
determining the flavour. These physicochemical events might influence lipid and protein bioaccessibility 35 
(Ayala-Bribiesca, Lussier, Chabot, Turgeon, & Britten, 2016).Besides cheese processing, milk origin also 36 
determines protein and lipid content. 98% of dairy lipids are triacyglycerides (TAG) (Ayala-Bribiesca, 37 
Turgeon, & Britten, 2017); being the three predominant free fatty acids (FFA) forming part of TAG the 38 
following: palmitic acid (C16:0), stearic acid (C18:0) and oleic acid (C18:1 cis (n-9)) (Ceballos et al., 2009). 39 
The origin of milk (cow, goat or sheep milk), also influences lipid digestibility, resulting goat milk fat in 40 
better digestibility as compared to cow milk fat (Alférez et al., 2001). 41 
 The intestinal environment as well as the intrinsic matrix composition of food have been reported 42 
to influence the digestion process (Calvo-Lerma, Fornés-Ferrer, Heredia & Andrés, 2018; Hur, Lim, 43 
Decker, & McClements, 2011). Lipid digestion requires complex mechanisms, such as biliar secretion to 44 
emulsify fat globules (fat micelles), making them accessible for the pancreatic enzymes. However, 45 
gastrointestinal environment can vary among different individuals (Shani-Levi et al., 2017). Concretely, 46 
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in the EPI scenario, the obstruction of the pancreatic duct results in deficient secretion of pancreatic juice 47 
containing pancreatin and sodium bicarbonate. Besides, alteration of the biliary duct can lead to a reduced 48 
secretion of bile salts. This situation causes mal-digestion and mal-absorption, mainly of fats (Whitcomb 49 
et al., 2010).To revert the situation, oral pancreatic enzyme replacement therapy is the life-long treatment 50 
patients have to adhere to Turck et al., 2016. 51 
In this context, the aim of the present study was to evaluate, by means of a static in vitro 52 
gastrointestinal digestion model, the influence of some intestinal conditions of pH (6 and7), bile 53 
concentration (1 and 10 mmol/L) and pancreatic supplementation (0-4000 Lipase Units (LU)/g fat) 54 
associated to EPI, on protein and lipid digestion in cheeses with different milk origin (cow or goat) and 55 
ripening time (mild or aged). 56 
 57 
2. Materials and methods 58 
2.1 Materials 59 
Four types of cheese were used in this study. On the one hand, two cheeses of different ripening 60 
conditions but with the same milk composition (55 % cow, 25 % sheep and 20 % goat):mild-cheese (30 61 
days of aging time)and aged-cheese (240 days of aging time). On the other hand, cheeses with the same 62 
elaboration process but different milk origin (100 % goat or 100 % cow): fresh goat cheese and fresh cow 63 
cheese, were also assessed. All cheeses were produced by “Queserías Entrepinares, S.A.U.” and 64 
distributed in a local supermarket in Valencia (Spain). 65 
The simulated digestive fluids were prepared with KCl, KH2PO4, NaCl, NaHCO3, MgCl2 (H2O)6, 66 
(NH4)2CO3, CaCl2, human α – amylase (1000 – 3000 U/ mg protein), pepsin from porcine gastric mucosa 67 
(≥2500 U/mg protein) and bovine bile extract all of them from Sigma-Aldrich Chemical Company (St 68 
Louis, MO, USA). The pancreatic enzymes supplements came from Kreon 10,000 LU (Mylan, USA), 69 
each capsule containing 150 mg of gastro-resistant microspheres including porcine pancreatic enzyme 70 
equivalent to 10,000 lipase units, 8,000 amylase units, and 600 protease units.  71 
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For the analytical determinations, Triton-X 100 %, trichloroacetic acid (TCA), hexane,and the 72 
analytical standards were acquired from Sigma-Aldrich Chemical Company (St Louis, MO, USA), and 73 
ethanol (95 % v/v for analysis), NaOH and HCl, were from AppliChem Panreac.  74 
 75 
2.2 Experimental design 76 
The experimental design consisted in two sets of experiments. In the first set, the dose of enzyme 77 
supplement was remained fixed at 2000 LU/g of fat, and the study variables were different combinations 78 
of intestinal pH and bile salts concentration (mmol/L): 6-1, 6-10, 7-1 and 7-10, with the purpose of 79 
analysing the impact of intestinal conditions on lipolysis and proteolysis. The intestinal condition of pH 6 80 
and 1 mmol/L would represent the worst unfavourable intestinal scenario in EPI (Gelfond, Ma, Semler, & 81 
Borowitz, 2013; Seksik et al., 2018). The intestinal condition of pH 7 and 10 mmol/L bile salts would 82 
correspond to the gastrointestinal scenario of a healthy subject (Minekus et al., 2014). In the second set, 83 
the intestinal conditions of EPI were simulated (pH 6 – 1 (mmol/L)) and different doses of enzyme 84 
supplement (0, 1000, 2000, 3000 and 4000 LU/g of lipid) were tested, in order to assess the influence of 85 
supplement concentration on lipolysis and proteolysis. A blank of digested fluids in each intestinal 86 
condition was also analysed in the absence of food. All the experiments were performed at least in 87 
triplicate.  88 
 89 
2.3 In vitro digestion 90 
Fat, water, carbohydrate and protein contents in all cheeses were determined before digestion with 91 
the official methods (AOAC, 2000). In vitro digestion was conducted on the basis of the INFOGEST Cost 92 
Action international protocol (Minekus et al., 2014) with some modifications in order to simulate EPI 93 
conditions (Asensio-Grau, Peinado, Heredia, & Andrés, 2018). Digestion fluids were prepared from the 94 
corresponding stock solutions according to Minekus et al. (2014). Before each experiment, the enzymatic 95 
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activity was cheeked according to the protocol published by Carriere et al. (2000). The In vitro digestion 96 
process was conducted as follows:  97 
Oral stage: Simulated Salivary Fluid (SSF; pH 7) was added to the cheese sample in a ratio 1:1 98 
(w/v) properly homogenized using a kitchen blender for 3 min at 37 ºC (Vario Mixer, Ufesa 600 W). 99 
Human α – amylase was added as a part of SSF to reach a concentration in the salival mixture of 75 U/ml. 100 
Gastric stage: Subsequently, Simulated Gastric Fluid (SGF; pH 3) was added to each tube in a 1:1 101 
(v/v) ratio including pepsin to reach a concentration in the gastric mixture of 2000 U/ml. The pH of the 102 
mixtures was adjusted with HCl (1 N) to pH 3. Tubes were head-over-heels rotated at 55 rpm for 2 h at 37 103 
°C using Intell – Mixer RM – 2 (Elmi Ltd, Riga, LV – 1006, Latvia) in an incubator chamber (JP Selecta 104 
SA, Barcelona). The pancreatic supplement was added at the gastric stage, mimicking the incorporation 105 
of pancreatic enzyme replacement therapy to the digestion process.  106 
Intestinal stage: After the gastric stage, Simulated Intestinal Fluid (SIF; pH 6 or 7) was added in 107 
1:1 (v/v) ratio to each tube containing the gastric chime. The mixtures were adjusted to pH 6 or 7, 108 
depending on the experimental set with NaOH (1N). Then, samples were rotated head-over-heels at 55 109 
rpm for 2 h at 37 ºC. During digestion, pH was controlled to keep the experimental conditions, as pH 110 
below 5.7 might inactivate lipase activity (González-Bacerio, Hernández, & Martínez, 2010; Prazeres, 111 
Garcia, & Cabral, 1994). 112 
 113 
2.4 Analytical determinations 114 
2.4.1 Matrix Degradation Index (MDI (%)) 115 
Matrix degradation Index (%) was calculated from the proportion of solids that were finely 116 
dispersed in the digested juice after the intestinal stage (Lamothe, Corbeil, Turgeon, & Britten, 2012).The 117 
total content of the tubes was centrifuged (4000 x g-force 20 min, 4 ºC) and then filtered on a metallic 118 
sieve (1.6 mm x 1.6 mm mesh)in order to separate the solid fraction. The liquid fraction was kept for 119 
lipolysis extent determination. The remaining liquid phase was freeze-dried (-40 °C and 1.25 mbar, 120 
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Telstar, Terrasa, Spain) and used for fatty acids profile analysis by gas chromatography. The solid large 121 
particles from digestion were transferred to an aluminium plate and then placed in a force air oven at 60 122 
°C for 48 hours to determine the mass of  large cheese particles.  123 
2.4.2 Proteolysis 124 
 Proteolysis was determined by measuring the soluble protein fraction in trichloroacetic acid 125 
(TCA) (Lamothe, Azimy, & Bazinet, 2014) at different times (0, 10, 20, 60, 90 and 120 min) during 126 
gastric and intestinal stages. Aliquots of digested samples were extracted and TCA was added to a final 127 
concentration of 15 % (w/w), and then centrifuged at 4000 g-force for 15 min at 4 ºC. Then, the 128 
supernatant containing the hydrolysed peptides was mixed with glycine buffer, and the absorbance (OD)  129 
measured at 280 nm using a spectrophotometer (UV/vis, Beckman Coulter). Proteolysis was estimated by 130 
considering two parameters ODmax and ΔOD/h initial from the mathematical model published by Bax, 131 
Aubry, Ferreira, Daudin, & Gatellier (2012) and using a Solver of Microsoft Excel in order to estimate 132 
calculate both parameters. 133 
2.4.3 Lipolysis extent (%) 134 
Aliquots from the liquid fraction of digested samples were diluted with a solution (5.6 % Triton 135 
X-100 and 6 %  ethanol in water) to solubilize free fatty acids ensuring lipase activity inactivation 136 
(Lamothe, Corbeil, Turgeon, & Britten, 2012). FrFA release after digestion was measured by means of an 137 
enzymatic kit (Roche Diagnostics, Indianapolis, IN, USA) using a spectrophotometer (UV/vis, Beckman 138 
Coulter). Palmitic acid standard was used for quantitative determination of FFA. Lipolysis extent (%) was 139 
expressed as the percentage of total fatty acids released after complete digestion, considering the 140 
maximum release of 2 fatty acids per 1 molecule of triacylglycerol and the average molecular weight of 141 
milk triglycerides 741 g/mol (Hunter, 2001). Lipolysis of the studied cheeses was also determined before 142 
digestion, to estimate lipid hydrolysis during ripening. 143 
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2.4.4. Free fatty acid profile 144 
Chromatography mass spectrometry (GC-MS) was used for identification of FFA from cheese 145 
before and after digestion. Undigested samples were subjected to a Soxhlet extraction (AOAC, 2000), 146 
while digested samples were extracted with hexane. Lipid samples needed a transesterification from fatty 147 
acids to methyl esters (FAMEs) with BF3 and methanol at 20 ºC 20°C according to the IUPAC standard 148 
method (Yaich et al., 2011). Then, samples were analysed with an Agilent 5977A system and an HP-5MS 149 
UI (Agilent) (Colum: 30 m x 0.25 mm, 0.25 μm film thickness) with helium as carrier agent (1 ml/min). 150 
Extraction, esterification and the analysis conditions were previously described by Paz-Yépez, Peinado, 151 
Heredia, & Andrés (2018). 152 
2.5 Statistical analyses 153 
Simple ANOVA analyses were performed to assess the statistical significance of the intestinal 154 
conditions variables, milk origin and maturation stage on MDI, proteolysis, lipolysis extent, and free fatty 155 
acid profile in digested cheeses. Statgraphics Centurion was used and the analyses were conducted with at 156 
least a significance of 95 %  (p-value < 0.05). 157 
 158 
3. Results and discussion 159 
3.1 Influence of the intestinal pH and bile concentration on macronutrients digestibility of different 160 
fresh and ripened cheeses 161 
As previously mentioned, the studied cheeses were characterized before digestion in terms of fat, 162 
protein and carbohydrate contents (g of each macronutrient/ g of dry matter). Fresh-cow cheese 163 
(0.32±0.03) presented lower fat content than the fresh-goat (0.50±0.06), mild (0.544±0.003) and aged 164 
cheeses (0.51±0.04). However, the protein content was similar in all of them (≈0.3 g/g dry matter). 165 
Regarding carbohydrate content, as expected, ripened cheeses presented less content (aged cheese 166 
(0.015±0.002) and mild cheese (0.022±0.003)) compared to fresh ones (fresh cow cheese (0.18±0.05) and 167 
fresh goat cheese (0.097±0.04)).These differences can be attributed to the different composition of cow 168 
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and goat milks, in terms of lipids for instance, and to the cheese-making process. In case of fresh cheeses, 169 
the rennet is immediately added after milk pasteurization, when temperature reaches 32-37 ºC 32-37ºC, 170 
and then mixed to coagulate the milk. After 30 minutes, draining and pressing proceed. Conversely, 171 
ripened cheeses are kept on a maturating chamber after coagulation, where the temperature and time of 172 
the process are controlled. This situation leads to ripened cheeses resulting in an additional loss of 173 
moisture content with an increase of protein and lipids in ripened cheeses compared to fresh ones, but in a 174 
lower carbohydrate content due to bacterial conversion of carbohydrates into other metabolic compounds. 175 
Table 1 reports the values for MDI (%) and lipolysis extent (%) achieved in cheeses digested at a 176 
fixed enzyme dose of 2000 LU/ g fat but different gastrointestinal conditions of pH (6 or 7) and bile 177 
concentration (1 or 10 mmol/L). As observed, both fresh cheeses presented higher MDI (%) under healthy 178 
conditions of pH 7 and bile concentration of 10 mmol/L; whereas in ripened cheeses, similar values of 179 
MDI (%) (between 73 and 81) were found regardless the intestinal conditions, and being higher than the 180 
values obtained for fresh varieties. During fresh cheese production, and directly after acidic or enzymatic 181 
coagulation of caseins, cheeses are pressed and packaged resulting in softer structures than those of the 182 
ripened ones, but with a very stable three-dimensional casein matrix (Pastorino, Hansen, & McMahon, 183 
2003). During the further ripening stage applied in the production of aged cheeses, proteolysis, lipolysis 184 
and the metabolism of residual lactose, lactate and citrate, are the three primary routes by which 185 
biochemical activity continues. The relative importance of each of these processes is largely dependent on 186 
cheese variety; however, proteolysis has been pointed out as the most complex mechanism, therefore 187 
playing a significant role during ripening of nearly all varieties. In fact, Karaman and Akalin (2013) 188 
reported a decrease of the hardness and cohesiveness in ripened cheeses as a consequence of proteolysis. 189 
In the same way, lipolysis contributes to the volatile compounds profile as well as to unctuousness. 190 
Therefore, proteolysis and lipolysis occurring during ripening stage could favour further matrix 191 
degradation during the gastrointestinal track. 192 
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Concerning lipolysis extent after digestion, complete lipolysis (≈ 100 %) was achieved in most of 193 
the studied cheeses under the standard healthy intestinal conditions (pH 7 and bile concentration 10 194 
mmol/L). However, these results also show that the different manufacturing processes can influence the 195 
bioavailability of lipids at suboptimal intestinal conditions of 6 and bile concentration of 1 mmol/L. 196 
Concretely, lipolysis was found to be higher in aged cheese and fresh goat cheese than in mild and fresh 197 
cow cheese at these intestinal conditions. Aged cheese showed a significant higher lipolysis extent 198 
compared to mild cheese, being the only difference between them the aging time: 30 days for mild and 199 
240 days for aged cheese. The lipolysis extent found in these cheeses before digestion was 1.6±0.3 % and 200 
3.4±0.5 %, respectively; while the extent of lipolysis in fresh cow and fresh goat cheese was around 201 
0.4±0.2 % in both cases. During ripening process, products of hydrolysis could enhance the further 202 
lipolysis during digestion because of their emulsifying capacity (Maldonado-Valderrama, Wilde, 203 
MacIerzanka & MacKie, 2011) 204 
Bile concentration played a crucial significant role on lipolysis attained in fresh cow cheese at 205 
both pH 6 and 7, and aged and mild cheese at pH 7. However, lipolysis extent was not affected in fresh 206 
goat cheese, with complete lipid hydrolysis regardless the intestinal pH or bile salt concentration. Goat 207 
milk is richer in short chain fatty acids than cow milk. Short chain fatty acids are easier to hydrolyse by 208 
lipases, becoming the role of bile salts or pH less important (Arora, Bhojak & Joshi, 2013).  Therefore, 209 
these results revealed that triglycerides from fresh goat cheese are more digestible than in fresh cow type, 210 
which increases their nutritional value and their health benefits. 211 
FFA profiles resulting from cheese digestion were determined in two intestinal scenarios, 212 
corresponding to the healthy situation (pH 7 and bile 10 mmol/L) and the EPI conditions (pH 6 and bile 1 213 
mmol/L) in order to deeper understand the consequences of the EPI disorder on lipid mal-digestion. 214 
Additionally, FFA profile of mild, aged, fresh goat and fresh cow cheeses (g FFA/100 g total fatty 215 
acids) was analysed prior digestion, and results are gathered in Table 2..The predominant FFAs found in 216 
all cheeses were lauric acid (C12:0), palmitic acid (C16:0)and stearic acid (C18:0) above saturated FFA; and 217 
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oleic acid (C18:1) over the unsaturated ones. Concretely, these four FFA entail the 85.8, 86.4, 83.8 and 218 
83.7 % of total FFA in aged, mild, fresh goat and fresh cow cheeses, respectively. Particularly, the main 219 
differences between fresh goat and fresh cow cheeses were found in the amounts of saturated fatty acids 220 
(C6:0, C8:0, C10:0, C12:0 and C20:0). Similar FFA distribution was reported for fresh goat and fresh cow 221 
cheeses in other studies (Ceballos et al., 2009; Rodríguez-Alcalá, Harte & Fontecha, 2009), differences 222 
beingattributed to milk origin. Aged and mild cheeses presented a very similar FFA profile, as expected, 223 
since they are made from the same mixture of milks, and in the same proportion, being the only 224 
difference between them the aging time. However, aged cheese presented a slightly, although statistically 225 
significant, higher amount of C12:0 (16.93 %) and C14:0 (3.007 %); while mild cheese showed a higher 226 
content in C18:0 (17.58%). The difference found in the content of myristic acid (C14:0) between fresh and 227 
ripened cheeses might be attributed to the action of lipolytic agents during the maturation process, such as 228 
enzymes from milk, rennet and the microflora.  229 
Regarding the influence of intestinal conditions on the FFA profile after digestion (Figure 1), the 230 
optimal conditions of pH 7 and bile 10 mmol/Lslightly increased the FFA released compared to the EPI 231 
conditions. An exception of this tendency was the FFA found in the digested aged cheese, for which 232 
slightly higher contents of saturated and unsaturated medium-long-chain fatty acids (C16:0, C18:0, C18:1 c, 233 
C18:1 t and C20) were found at pH 6 and 1 mmol/L of bile salts. When comparing FFA profile of the four 234 
digested cheeses, one gram of digested fat of fresh goat cheese presented considerably higher quantities 235 
of all FFA than the same fat amount of fresh cow cheese. Likewise, the FFA profile of digested aged 236 
cheese was richer in all the identified FFA than mild cheese. These results again evidence the easier 237 
digestibility of fresh cheeses made from goat milk and cheeses subjected to long maturation time. 238 
Therefore, consumption of fresh goat and aged cheeses would be advisable for EPI patients with 239 
suboptimal intestinal conditions.   240 
Concerning proteolysis, Table 3 shows the initial slope (ΔOD/hinitial) and the maximum protein 241 
hydrolysis (ODmax) of the different cheeses digested under different intestinal conditions. ODmax can be 242 
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considered as an indicator of the proteolysis extent, while the initial slope (ΔOD/hinitial) refers to the 243 
kinetics of the initial proteolytic reactions (Bax, Aubry, Ferreira, Daudin, & Gatellier, 2012). Both 244 
parameters were determined during and at the end of gastric and intestinal stages. Remarkably, all the 245 
studied cheeses presented similar protein content (g/g dry matter). 246 
According to the obtained results, proteolysis resulting from gastric pepsin activity was higher in 247 
aged and fresh cow cheeses, and much lower than in the intestinal stage for all cheeses. The hydrolysis of 248 
protein achieved in fresh cow cheese is especially relevant because the Protease Units (PU)/g protein was 249 
lower for this cheese in comparison with the others. Other studies, however, showed that goat milk 250 
caseins were more efficiently digested compared to cow milk ones (Hodgkinson, Wallace, Boggs, 251 
Broadhurst, & Prosser, 2018), in our study, gastric pepsin seemed to present more affinity for caseins of 252 
cow cheese than for other kind of cheeses. Bovine milk proteins are similar to those of goat milk, but they 253 
present different genetic polymorphisms. These differences are due to amino acids substitutions in protein 254 
chains, and lead to different digestibility fates (Haenlein, 2004). 255 
On the other hand, higher proteolysis (ODmax) was found at the end of gastrointestinal digestion 256 
for both ripened cheeses when compared to fresh ones, and particularly than in fresh goat cheese that was 257 
digested under similar PU/ g protein, and thus comparable to the ripened ones. As previously mentioned, 258 
both, salting and ripening stages, favoured the proteolytic activity, giving as a result an increase of free 259 
amino acids and small peptides in ripened cheese, coming from casein degradation (McSweeney, 2004). 260 
As it was expected, pH 7 instead of 6 promoted higher proteolysis extent. In fact, it is well-known that the 261 
optimal pancreatic proteases activity is around pH 7.5. However, neither intestinal pH nor bile 262 




3.2 Influence of oral pancreatic supplementation on macronutrients digestibility of different fresh and 265 
ripened cheeses 266 
The impact of the oral supplement dose on macronutrient digestibility was also assessed. Figure 2 267 
shows the results of the MDI (%) and lipolysis extent (%) at different enzymatic dosages (1000-4000 268 
LU/g lipid) and at EPI fixed intestinal conditions of pH 6 and bile concentration 1 mmol/L. Table 4 269 
gathers the results of proteolysis under the same conditions. As previously stated commented, MDI (%) 270 
did not seem to depend on intestinal conditions (Table 1), but on cheese-related factors and especially of 271 
ripening. Similarly, the supplementation with pancreatin only increased MDI (%) of digested fresh goat 272 
cheese, irrespective from the dosage. On the contrary, lipolysis extent (%) was highly dependent on 273 
pancreatin dose, increasing gradually as long as it did. Figure 2 shows that fresh goat cheese reached the 274 
maximum value of lipolysis extent (≈100 % 100%) at 2000 LU/ g fat. Fresh cow cheese, in contrast, 275 
required a higher dose (4000 LU/g fat) to reach a lipolysis extent of ≈65 % 65%. In fact, fresh cow 276 
cheese, 100 %made from cow milk, seemed to be the less digestible in terms of lipids. The difference 277 
might be due to the fat origin from milk (cow or goat). Goat milk presents higher concentration of short 278 
and medium chain fatty acids (C6 to C12) than cow milk. Consequently, this matrix allowed for greater 279 
release of free fatty acids. Some authors reported that goat milk has smaller fat globule size than cow 280 
milk, whereby led to greater rates of lipolysis in cheese made from goat milk(Ceballos et al., 2009; Logan 281 
et al., 2017; Park, 2001). Lower fat globule size leads to an increase of the total fat globules surface, 282 
apparently enhancing fat digestibility. Furthermore, aging time also affected lipolysis. The highest 283 
lipolysis extent in digested aged cheese (≈80%) and digested mild cheese (≈45%) was achieved at 2000 284 
LU/ g fat. In both cheeses, the increment of pancreatic dose above 2000 LU/ g fat did not improve the 285 
lipid digestibility. 286 
As shown in Table 4, the initial kinetics of proteolysis was faster (higher values of initial slope) in 287 
cheeses subjected to maturation than in fresh ones, independently of the enzymatic supplement dosage. 288 
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Small peptides and free amino acids resulting from proteolysis occurring during aging act as bio-289 
catalysers, enhancing the kinetics of the further proteolysis during digestion (Tavano, 2013). Proteolysis 290 
occurred faster in fresh cow cheese than in fresh goat cheese, considering the results of initial slope at 291 
2000 LU/ g lipid (194 PU/g protein) in fresh goat cheese, and 3000 LU/ g lipid (171 PU/g protein) in 292 
fresh cow. Overall, Table 4 illustrates that high doses of enzyme supplement seem to be associated with a 293 
reduction of the initial slope in aged and fresh cow cheeses. These results can validate the hypothesis that 294 
proteolysis extent decreases when a certain dose of enzyme supplement is present. This result could be 295 
attributed to two phenomena. Enzyme auto-aggregation, over a certain limit of concentration, together 296 
with product inhibition, could leads proteases inactivation. This second phenomenon could be especially 297 
relevant in in vitro static models of digestion because of products of proteolysis are not gradually 298 
removed from the system. In terms of maximum proteolysis, similar values for fresh cheeses at the same 299 
PU/g protein were found. On the other hand, the presence of pancreatic proteases was essential to 300 
accomplish casein hydrolysis during intestinal stage, but without significant relevance of the protease 301 
dose. During cheese manufacturing, rennet is added to milk causing casein hydrolysis and leaving milk 302 
serum free. As a result, an increase in the attractive forces is produced between micelles found in milk, 303 
resulting in the formation of casein aggregates that maintain fat globules and serum retained inside the 304 
protein matrix (McSweeney, 2004).The importance of protein hydrolysis and lipolysis during cheese 305 
processing should be considered since the resultant matrices of milk and cheese are completely different. 306 
4. Conclusions 307 
The present study points out that the type of cheese and together with the host-individual 308 
gastrointestinal conditions influence lipids and proteins digestibility. Even if lipolysis was completed 309 
(≈100 %) for all cheeses under the healthy intestinal conditions; goat-fresh cheese and aged cheese 310 
achieved higher lipolysis extent under EPI conditions lipolysis than cow-fresh cheese and mild-cheese.  311 
Concerning protein digestibility, it was only dependent on the characteristics of cheeses, being 312 
higher in fresh-cow cheeses and matured ones than in fresh-goat cheese. Results also demonstrate that 313 
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some dairy matrix properties, milk origin and ripening time, greatly affect lipolysis in the EPI situation. 314 
Concretely, aged and fresh-goat cheeses reached the maximum value of lipolysis extent, 80 %  and 100 % 315 
respectively, at 2000 LU/g fat; whilst lipolysis remained incomplete in fresh-cow cheese and mild-316 
cheeses even at the highest dose of 4000 LU/g fat. 317 
To conclude, this study has unveiled the implication of food characteristics and host-related 318 
factors on lipid and protein digestibility in cheese products. Our findings could contribute to establish 319 
dietary recommendations for pancreatic insufficient patients, including the promotion of matured cheese 320 
consumption, as it would be the most easily digested. 321 
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 442 
Figure captions 443 
Figure 1. FFA profile of different cheese matrices after in vitro digestion simulating two intestinal 444 
scenarios corresponding to a healthy adult (pH 7 and bile 10 mmol/L) and the most 445 
disadvantageous EPI conditions (pH 6 and bile 1 mmol/L). A: pH 6 Bile 1 mmol/Lfresh goat 446 
cheese ; pH 6 Bile 1 mmol/Lfresh cow cheese ; pH 7 Bile 10 mmol/Lfresh goat cheese ; 447 
pH 7 Bile 10 mmol/Lfresh cow cheese . B: pH 6 Bile 1 mmol/Lmild cheese ; pH 6 Bile 1 448 
mmol/Laged cheese ; pH 7 Bile 10 mmol/Lmild cheese ; pH 7 Bile 10 mmol/Laged cheese449 
. 450 
a – c Letters refer to the homogenous groups obtained for different cheese (mild, aged, fresh cow 451 
and fresh goat cheeses) for the same fatty acid (C6, C8, C10, C12, C14, C16, C18, C18:1c, 452 
C18:1t, C18:2 and C20) and at a statistical significance of statistical significance of 95 % (p-value 453 
< 0.05). 454 
 455 
Figure 2. Matrix degradation index (%) (A) and Lipolysis extent (%) (B) obtained for the 456 
different cheese matrices (mild cheese ; aged cheese  ; fresh cow cheese  ; fresh goat 457 
cheese )after in vitro digestion at fixed duodenal conditions of pH 6 and Bile concentration 1 458 
mmol/L using different doses of Kreon (0-4000 LU/ g fat). a – c Letters refer to the homogenous 459 
groups obtained for different doses (0 – 4000) for the same cheese matrix (mild, aged, fresh cow 460 
and fresh goat cheeses) at a statistical significance of 95% (p-value < 0.05). 461 
 462 
